EFSA publishedl a reasoned opinion on the toxicological properties and MRLs of the benzimidazoles carbendazim and thiophanate-methyl.
14th September 2021
EFSA reasoned opinion on benzimidazoles
14September
18th November 2020
RoQ 18.11.2020
18November
imazalil, carbendazim, thiophanate-methyl, cumulative risk assessment cranio-facial malformations, in vitro testing battery workshop, DNT in vitro battery vs in vivo endpoints, Birds & Mammals...